Remove 2016 Remove Bioinformatics Remove Document
article thumbnail

In Silico Modeling Unveils a New Era in Rare Disease Drug Development

The Premier Consulting Blog

More recently, some key events that have enabled acceptance of in silico trials for evaluating treatments for rare diseases include: In 2016, the FDA formed the Modeling and Simulation Working Group to support the implementation of CM&S in the regulatory review process. BMC Bioinformatics 2020, 21(Suppl 17):527 [link]

article thumbnail

FAIR Game: making data work harder in the race to marketĀ 

Drug Discovery World

As a backdrop to this informatics ecosystem, it can be helpful to tap into a set of guiding principles established in 2016 to support improved scientific data management and stewardship, the FAIR Principles. .

Marketing 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Codon Guide to Synthetic Biology

Codon

This guide is a living document. Philosophical Transactions of the Royal Society B (2016). Nature (2016). Science (2016). Nature (2016). Essays in Biochemistry (2016). So I spent the last week scouring the web and racking my brain for useful resources on synthetic biology. & Charpentier E. & Liu D.R.

DNA 94
article thumbnail

The Codon Guide to Synthetic Biology

Codon

This guide is a living document. Philosophical Transactions of the Royal Society B (2016). Nature (2016). Science (2016). Nature (2016). Essays in Biochemistry (2016). So I spent the last week scouring the web and racking my brain for useful resources on synthetic biology. → means “start here.”

DNA 52